QTAS GmbH
The gate-Startup QTAS develops next-generation quantum sensing technologies for liquid biopsies, enabling ultra-sensitive detection and characterization of biomarkers and rare cells in blood and cerebrospinal fluid. The focus of QTAS lies on enabling highly sensitive downstream analyses such as single-cell sequencing and molecular profiling, particularly for neuro-oncological applications. The MedTech startup was founded in 2025 … Read more